
    
      This is a prospective observational study. After IRB approval, consecutive patient with upper
      GI bleeding and undergoing urgent endoscopy will be enrolled to the study over 24 months
      period. Data pull will be requested from Parkland Office of Research Administration (ORA)
      regarding eligible subjects and protocol requiring data elements. The data pull will be
      requested at the end of the 24 months-period.

      Primary endpoint:

      The incidence of cardiovascular unplanned event within 48 hours of the upper gastrointestinal
      endoscopy procedure.

      Secondary end points:

      The incidence of pulmonary unplanned event within 48 hours of the upper gastrointestinal
      endoscopy procedure.
    
  